Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomes

7 Jan 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research
Share to T-cell and B-cell Immunology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35007990
DOI: 10.1016/j.copbio.2021.12.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomesPMID 35007990Read ↗

Nanomedicine for Cancer and Autoimmune ImmunotherapySemantic proximity Read ↗

Autoimmune disease is the next frontier for CAR T cell therapySemantic proximity Read ↗

Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseasesSemantic proximity Read ↗

Vaccine against autoimmune disease: antigen-specific immunotherapySemantic proximity Read ↗

Exosomes in Autoimmune Diseases: A Review of Mechanisms and Diagnostic ApplicationsSemantic proximity Read ↗

Chimeric antigen receptor T cell therapy for autoimmune diseaseSemantic proximity Read ↗

T cells as therapeutic targets in SLESemantic proximity Read ↗

CAR-T AND autoimmune diseases in nervous systemSemantic proximity Read ↗

Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells.Semantic proximity Read ↗

La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune diseaseSemantic proximity Read ↗

Advances in hematopoietic stem cell transplantation for autoimmune diseasesSemantic proximity Read ↗

Bridging the gender gap in autoimmunity with T-cell-targeted biomaterials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.